Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bamipine
2. Bamipine Citrate
3. Bamipine Dihydrochloride
4. Bamipine Dihydrochloride, Hydrate
5. Bamipine Ethanol Hydrate
6. Bamipine Monohydrochloride
7. Bampine Hydrochloride
8. Soventol
1. 61670-09-5
2. 6k8knj07d8
3. Soventol (tn)
4. N-benzyl-1-methyl-n-phenylpiperidin-4-amine;2-hydroxypropanoic Acid
5. Unii-6k8knj07d8
6. Einecs 262-887-2
7. Schembl2968324
8. Bamipine Lactate [who-dd]
9. Lactic Acid, Compound With N-benzyl-1-methyl-n-phenylpiperidin-4-amine (1:1)
10. Multifungin Component Bamipine Lactate
11. Ns00086627
12. D07493
13. Bamipine Lactate Component Of Multifungin
14. Q27265044
15. 4-piperidinamine, 1-methyl-n-phenyl-n-(phenylmethyl)-, Mono(2-hydroxypropanoate)
Molecular Weight | 370.5 g/mol |
---|---|
Molecular Formula | C22H30N2O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 64 |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 343 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
ABOUT THIS PAGE
85
PharmaCompass offers a list of Bamipine lactate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bamipine lactate manufacturer or Bamipine lactate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bamipine lactate manufacturer or Bamipine lactate supplier.
PharmaCompass also assists you with knowing the Bamipine lactate API Price utilized in the formulation of products. Bamipine lactate API Price is not always fixed or binding as the Bamipine lactate Price is obtained through a variety of data sources. The Bamipine lactate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EINECS 262-887-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EINECS 262-887-2, including repackagers and relabelers. The FDA regulates EINECS 262-887-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EINECS 262-887-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EINECS 262-887-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EINECS 262-887-2 supplier is an individual or a company that provides EINECS 262-887-2 active pharmaceutical ingredient (API) or EINECS 262-887-2 finished formulations upon request. The EINECS 262-887-2 suppliers may include EINECS 262-887-2 API manufacturers, exporters, distributors and traders.
click here to find a list of EINECS 262-887-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
EINECS 262-887-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EINECS 262-887-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EINECS 262-887-2 GMP manufacturer or EINECS 262-887-2 GMP API supplier for your needs.
A EINECS 262-887-2 CoA (Certificate of Analysis) is a formal document that attests to EINECS 262-887-2's compliance with EINECS 262-887-2 specifications and serves as a tool for batch-level quality control.
EINECS 262-887-2 CoA mostly includes findings from lab analyses of a specific batch. For each EINECS 262-887-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EINECS 262-887-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (EINECS 262-887-2 EP), EINECS 262-887-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EINECS 262-887-2 USP).